Prostate cancer screening: contrasting trends

Cancer Causes and Control

Volumn 26, Issue 6, 2015, Pages 949-952

  Eisinger, F ^a   Morere J F ^b   Touboul, C ^c   Pivot, X ^d   Coscas, Y ^e   Blay, J Y ^f   Lhomel, C ^g   Viguier, J ^h  

^a INSTITUT PAOLI CALMETTES   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c KANTAR HEALTH   (United States)

^d UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^e Clinique de la Porte de St Cloud   (France)

^f CENTRE LÉON BÉRARD   (France)

^g Laboratoire Roche Pharma   (France)

^h UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Controversy; Guidelines; Prostate cancer; Screening; Socioeconomic status; Trends

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FRANCE; HOUSEHOLD; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; SAMPLE SIZE; SOCIAL STATUS; TELEPHONE INTERVIEW; EARLY CANCER DIAGNOSIS; MASS SCREENING; MIDDLE AGED; PROSTATIC NEOPLASMS; TRENDS;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; EARLY DETECTION OF CANCER; FRANCE; HUMANS; INCOME; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84929705189     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0573-9     Document Type: Article

References (19)

1. Sarfaty M, Wender R, Smith R (2011) Promoting cancer screening within the patient centered medical home. CA Cancer J Clin 61(6):397–408
2. Eisinger F, Morere J, Touboul C, Viguier J, Blay J, Coscas Y, Lhomel C, Pivot X (2014) Vulnerable populations and overconfidence in cancer screening. J Clin Oncol 32 (Suppl):abstr 1574
3. Wakefield MA, Loken B, Hornik RC (2010) Use of mass media campaigns to change health behaviour. Lancet 376(9748):1262–1271
4. Salomon L, Peyromaure M, Mongiat-Artus P, Roset F, Gachignard N, Bastide C, Richaud P, Beuzeboc P, Cornud F, Molinie V, Soulie M, Benchikh El Fegoun A (2010) What’s new in 2009 in prostate cancer: highlights from ASTRO, EAU, ASCO and AUA meetings. Prog Urol 20(Suppl 1):S61–S67. doi:10.1016/s1166-7087(10)70030-0
5. HAS (2010) Dépistage du cancer de la prostate. Analyse critique des articles issus des études ERSPC et PLCO publiés en mars 2009. Haute Autorité de Santé, France
6. Eisinger F, Blay J, Morère J, Rixe O, Calazel-Benque A, Cals L, Coscas Y, Dolbeault S, Namer M, Serin D, Roussel C, Pivot X, Committee E (2008) Cancer screening in France: subjects’ and physicians’ attitudes. Cancer Causes Control 49(4):431–434
7. Eisinger F, Blay J, Pivot X, Morère J, Coscas Y, Calazel-Benque A, Roussel C, Viguier J (2011) Screening for prostate cancer: growth without control. Eur J Cancer Prev 20(Suppl 1):S33–S35
8. Deville J (1991) A theory of the quota surveys. Surv Methodol 17:173–181
9. Roussel C, Touboul C (2011) Large population survey: strengths and limits. Methodology of the EDIFICE survey. Eur J Cancer Prev 20(Suppl 1):S5–S7
10. Tuppin P, Samson S, Perrin P, Ruffion A, Millat B, Weill A, Ricordeau P, Allemand H (2012) Prostate-specific antigen use among men without prostate cancer in France (2008–2010). Bull Cancer 99(5):521–527
11. Blay J, Eisinger F, Rixe O, Calazel-Benque A, Morère J, Cals L, Coscas Y, Dolbeault S, Namer S, Serin D, Roussel C, Pivot X (2008) Edifice program: analysis of screening exam practices for cancer in France. Bull Cancer 95(11):1067–1073
12. Barry MJ (2009) Screening for prostate cancer—the controversy that refuses to die. N Engl J Med 360(13):1351–1354
13. Moyer VA, Force USPST (2012) Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 157(2):120–134
14. Lawrentschuk N, Daljeet N, Trottier G, Crawley P, Fleshner NE (2011) An analysis of world media reporting of two recent large randomized prospective trials investigating screening for prostate cancer. BJU Int 108(8 Pt 2):E190–E195
15. Aslani A, Minnillo BJ, Johnson B, Cherullo EE, Ponsky LE, Abouassaly R (2014) The impact of recent screening recommendations on prostate cancer screening in a large health care system. J Urol 191(6):1737–1742. doi:10.1016/j.juro.2013.12.010
16. Cohn JA, Wang CE, Lakeman JC, Silverstein JC, Brendler CB, Novakovic KR, McGuire, Helfand BT (2014) Primary care physician PSA screening practices before and after the final US Preventive Services Task Force recommendation. Urol Oncol. doi:10.1016/j.urolonc.2013.04.013
17. Weeks BE, Friedenberg LM, Southwell BG, Slater JS (2012) Behavioral consequences of conflict-oriented health news coverage: the 2009 mammography guideline controversy and online information seeking. Health Commun 27(2):158–166
18. McAlearney AS, Oliveri J, Post DM, Song PH, Jacobs E, Waibel J, Harrop JP, Steinmann K, Paskett ED (2012) Trust and distrust among Appalachian women regarding cervical cancer screening: a qualitative study. Patient Educ Couns 86(1):120–126
19. Eisinger F, Cals L, Calazel-Benque A, Blay J, Coscas Y, Dolbeault S, Namer M, Pivot X, Rixe O, Serin D, Roussel C, Morère J, Committee E (2008) Impact of organised programs on colorectal cancer screening. BMC Cancer 8:104